<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03203980</url>
  </required_header>
  <id_info>
    <org_study_id>2017-A01733-50</org_study_id>
    <nct_id>NCT03203980</nct_id>
  </id_info>
  <brief_title>Bleeding Events After Triple Antithrombotic Therapy Initiation.</brief_title>
  <acronym>HEMOTRI</acronym>
  <official_title>Bleeding Events After Triple Antithrombotic Therapy Initiation: a Prospective Observational Study in Real Life</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The optimal antithrombotic therapy for patients requiring anticoagulation after coronary
      stenting is unknown. Double platelets suppressive agents combined with oral anticoagulation
      (triple antithrombotic therapy) remains the Gold standard.

      Our study aims at studying bleeding events occurring until 6 months after the initiation of
      triple antithrombotic therapy.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 15, 2017</start_date>
  <completion_date type="Anticipated">July 15, 2018</completion_date>
  <primary_completion_date type="Anticipated">January 15, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Bleeding events</measure>
    <time_frame>within 6 months since the initiation of triple antithrombotic therapy</time_frame>
    <description>Bleeding events with clinical significance</description>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Bleeding</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Triple antithrombotic therapy</intervention_name>
    <description>patients who are prescribed double antiplatelets agents and oral anticoagulation (except VKA)</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients from the cardiology care unit of Nancy Central Hospital, hospitalised for coronary
        stenting and requiring oral anticoagulation (except VKA)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients requiring triple antithrombotic therapy, including double antiplatelets
             agents and oral anticoagulation

        Exclusion Criteria:

          -  history of bleeding

          -  patients already under triple antithrombotic therapy

          -  patients under vitamin K antagonists
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 28, 2017</study_first_submitted>
  <study_first_submitted_qc>June 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 29, 2017</study_first_posted>
  <last_update_submitted>July 6, 2017</last_update_submitted>
  <last_update_submitted_qc>July 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

